Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

China flag China · Delayed Price · Currency is CNY
6.80
-0.23 (-3.27%)
Apr 30, 2026, 3:00 PM CST
32.04%
Market Cap 3.76B
Revenue (ttm) 1.76B
Net Income (ttm) 60.00M
Shares Out 552.92M
EPS (ttm) 0.11
PE Ratio 62.67
Forward PE n/a
Dividend 0.01 (0.20%)
Ex-Dividend Date Jan 9, 2026
Volume 25,409,743
Average Volume 20,798,153
Open 7.00
Previous Close 7.03
Day's Range 6.72 - 7.02
52-Week Range 5.01 - 9.44
Beta 0.79
RSI 41.58
Earnings Date Apr 15, 2026

About SHA:600222

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, pediatric Qingrezhike oral liquid, Huoxiangzhengqi mixture, Danshen and Wuzi Yanzong oral liquid, Shengmaiyin, pediatric compound chicken gizzard chewable tablets, Huperzine A tablets, compound Yimu oral liquid. The company serves hospitals, primary medical institutions, and retail terminals. Henan T... [Read more]

Sector Healthcare
Founded 1993
Employees 2,214
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600222
Full Company Profile

Financial Performance

In 2025, SHA:600222's revenue was 1.76 billion, a decrease of -9.46% compared to the previous year's 1.94 billion. Earnings were 60.00 million, an increase of 18.74%.

Financial Statements

News

There is no news available yet.